Acute Myeloid Leukemia – Epidemiology – Europe Data

  • The total number of incident cases of AML (excluding APL) in the European countries under study will increase by 17% over the forecast period, from 4,700 in 2017 to 5,400 in 2027.
  • The total number of incident cases of APL in the European countries under study will increase by 1% over the forecast period, from 310 in 2017 to 320 in 2027.
  • 25% of the diagnosed incident cases of AML have FLT3ITD mutations, and 5% have FLT3TKD mutations.

Table of contents

  • Acute Myeloid Leukemia - Epidemiology - Europe Data
    • Introduction
      • Key Findings
        • Overview
          • Diagnosed Incidence of Acute Myeloid Leukemia per 100,000 People of All Ages per Year in 2017 and 2027tttttttttttttttttttttt
          • Diagnosed Incidence of Acute Promyelocytic Leukemia per 100,000 People of All Ages per Year in 2017 and 2027ttttttttt
          • Relative Sizes of the Factors Contributing to the Trend in Incident Cases of Acute Myeloid Leukemia over the Next Ten Yearsttttttttt
          • Relative Sizes of the Factors Contributing to the Trend in Incident Cases of Acute Promyelocytic Leukemia over the Next Ten Yearsttttttttt
      • Epidemiology Data
      • Methods
        • Diagnosed Prevalent Cases
        • Newly Diagnosed Incident Cases
        • FLT-3 Mutation
        • Lifetime DALYs Gained
      • Reference Materials
        • Literature Review
          • Studies Included in the Analysis of Acute Myeloid Leukemia
          • Studies Excluded from the Analysis of Acute Myeloid Leukemia
        • Risk/Protective Factors
          • Risk/Protective Factors for Acute Myeloid Leukemia
        • Bibliography